Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-02 Sale | 2024-04-03 5:23 pm | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 7,523 | $6.94 | $52,210 | 95,665 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-30 Option Award | 2024-10-03 8:58 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 1,710 | $4.45 | 22,375 (Direct) | View |
| 2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:23 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 25,000 | $0 | 95,665 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 08:30 am | N/A 2034-03-12 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 300,000 | $0 | 300,000 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 5:36 pm | N/A 2033-06-08 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 4:05 pm | N/A 2033-03-31 | Inozyme Pharma Inc. | INZY | Treco Douglas A CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 07:52 am | N/A 2032-06-09 | Inozyme Pharma Inc. | INZY | Treco Douglas A Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:44 pm | N/A 2032-06-09 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-24 4:16 pm | N/A 2031-06-22 | Inozyme Pharma Inc. | INZY | Treco Douglas A Director | 9,367 | $0 | 9,367 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:39 pm | N/A 2031-06-10 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2020-07-23 Option Award | 2020-07-24 4:50 pm | N/A 2030-07-22 | Inozyme Pharma Inc. | INZY | Treco Douglas A Director | 9,367 | $0 | 9,367 (Direct) | View |
Ownership | 2020-07-23 9:21 pm | N/A 2030-05-27 | Inozyme Pharma Inc. | INZY | Treco Douglas A Director | 0 | $0 | 86,979 (Direct) | View |
| 2020-06-11 Option Award | 2020-06-15 4:45 pm | N/A 2030-06-11 | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 30,000 | $0 | 30,000 (Direct) | View |
Ownership | 2020-06-15 4:42 pm | N/A N/A | CRISPR Therapeutics AG | CRSP | Treco Douglas A Director | 0 | $0 | 2,000 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A 2025-12-10 | Ra Pharmaceuticals Inc. | RARX | Treco Douglas A President and CEO | 1,226,949 | $0 | 0 (Direct) | View |
| 2020-04-02 Disposition | 2020-04-03 09:02 am | N/A N/A | Ra Pharmaceuticals Inc. | RARX | Treco Douglas A President and CEO | 234,707 | $48 | 0 (Direct) | View |